Biosimilar Retacrit™ (Epoetin Zeta) in the Treatment of Chemotherapy-Induced Symptomatic Anaemia in Haematology and Oncology

NCT01626547 · clinicaltrials.gov ↗

COMPLETED

Status

291

Enrollment

INDUSTRY

Sponsor class

Conditions

Chemotherapy-induced Symptomatic Anaemia
Solid Tumours
Malignant Lymphomas
Multiple Myeloma

Sponsor

Hospira, now a wholly owned subsidiary of Pfizer